| News
According to a press release, Raimondo Ascione, Saadeh Suleiman (Bristol Heart Institute, University of Bristol, Bristol, UK) and colleagues are to develop and test a new drug combination that could protect the hearts of patients undergoing cardiac surgery. They will...
| News
The PrecludeSync Distal (Merit Medical) is now available in the US, European, Middle Eastern, African, and Asia-Pacific markets. The device is the first product specifically designed to achieve haemostasis of the radial artery during procedures where access is gained...
| News
Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FIH) clinical trial, and the successful first “in-human” implantation of the V-LAPTM monitoring device. A press release reports that the trial will enrol up to 30 patients...
| News
A programme designed to help myocardial infarction patients with the transition from hospital to outpatient care can reduce readmissions and deaths and increase the number of patients keeping follow-up appointments, a new study suggests. The study—from the Sanger...
